Suppr超能文献

2022年山西省某公立医院药品不良反应报告分析

Analysis of Adverse Drug Reaction Reports from a Public Hospital in Shanxi Province in 2022.

作者信息

Zhang Xiao-Jie, Zhou Jian-Guo, Pan Miao, Yuan Wei, Gao Bo

机构信息

Department of Pharmacy, General Hospital of Yangquan Coal Industry Group, Yangquan, People's Republic of China.

Department of Oncology and Interventional Radiology, Yangquan Hospital of Shanxi Medical University, Yangquan, People's Republic of China.

出版信息

Risk Manag Healthc Policy. 2023 Aug 4;16:1391-1401. doi: 10.2147/RMHP.S418386. eCollection 2023.

Abstract

OBJECTIVE

Through analyzing the characteristics and influencing factors of adverse drug reactions/adverse events (ADR/ADE) in a hospital to promote rational drug use in the clinic.

METHODS

A total of 1221 ADR/ADE reports collected from a hospital in 2022 were retrieved through the National Adverse Drug Reaction Monitoring Center. The effective reports were screened according to the Guiding Principles for Collection and Reporting of Individual Adverse Drug Reactions, and classified the standardized drugs. The systems/organs and main clinical symptoms affected by ADR/ADE were classified according to the WHO Glossary of Adverse Drug Reaction Terms. The severity, age and gender, occupational distribution, drug category, route of administration, drug dosage form, system/organ involved, and main clinical symptoms of ADR/ADE reports were analyzed.

RESULTS

Among 1221 ADR/ADE reports, 890 cases (75.27%) reported by doctors; 144 cases (11.79%) were serious; Precisely 49.22% of ADR/ADE occurred in patients aged 51 to 70 years old; The highest incidence of adverse reactions was 636 cases (52.09%) by intravenous infusion, 406 cases (33.25%) by oral administration. The top categories of reported cases were anti-infective drugs (29.40%) and anti-tumor drugs (27.52%); Systems/organs involved in ADR/ADE were mainly the skin and its accessories (24.96%) and blood system (21.35%). 166 cases were cured, 893 cases were symptomatic, 160 cases were unknown, and 2 cases had sequelae.

CONCLUSION

The occurrence of ADR/ADE is related to many influencing factors such as age, drug categories, and route of administration. Therefore, it is recommended that hospitals strengthen the monitoring of ADR/ADE, especially the elderly, anti-infective drugs and intravenous administration.

摘要

目的

通过分析某医院药品不良反应/不良事件(ADR/ADE)的特点及影响因素,促进临床合理用药。

方法

通过国家药品不良反应监测中心检索某医院2022年收集的1221份ADR/ADE报告。依据《药品不良反应报告和监测管理办法》筛选有效报告,并对药品进行标准化分类。按照世界卫生组织药品不良反应术语集对ADR/ADE累及的系统/器官及主要临床症状进行分类。分析ADR/ADE报告的严重程度及年龄、性别、职业分布、药品类别、给药途径、药物剂型、累及系统/器官和主要临床症状。

结果

1221份ADR/ADE报告中,医生上报890例(75.27%);严重报告144例(11.79%);49.22%的ADR/ADE发生在51~70岁患者中;不良反应发生率最高的给药途径为静脉滴注636例(52.09%),口服给药406例(33.25%);报告病例数最多的药品类别为抗感染药(29.40%)和抗肿瘤药(27.52%);ADR/ADE累及的系统/器官主要为皮肤及其附件(24.96%)和血液系统(21.35%)。治愈166例,好转893例,不详160例,有后遗症2例。

结论

ADR/ADE的发生与年龄、药品类别、给药途径等多种影响因素有关。建议医院加强ADR/ADE监测,尤其是老年患者、抗感染药及静脉给药。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验